LJI welcomes new faculty member Miguel Reina-Campos, Ph.D.
The new Reina Lab aims to charge up killer T cells against tumors
A step toward personalized immunotherapy for all
"The potential for a 'cure from within' is in every cancer patient we've looked at..."
Studying T cell immunology in engineered animal models – Nikhil Joshi, Phd
T cells have the amazing ability to differentiate into many subtypes of T cells, all with different jobs in the
How T cells combat tuberculosis
By tracking T cell activity, researchers uncover promising tuberculosis vaccine and drug targets
A leader in allergy research retires
LJI Professor Emeritus Toshiaki Kawakami, M.D., Ph.D., uncovered the molecular underpinnings of allergy, tumor responses, and more
Immunologic and Metabolic Profiling + Responses to COVID-19 – Andrea L. Cox, M.D., Ph.D.
In this seminar, Dr. Andrea L. Cox, M.D., Ph.D., shares her research into “Immunologic and Metabolic Profiling of the Response
Common cold or COVID-19? Some T cells are ready to combat both
New LJI research demonstrates the importance of harnessing "cross-reactive" T cells to combat SARS-CoV-2
How ‘late-rising’ T cells combat a stubborn virus
LJI researchers uncover special T cell subset that helps fight cytomegalovirus infection
Researchers discover potentially cancer-fighting T cells within some pediatric brain tumor patients
New research suggests a small group of pediatric brain tumor patients may benefit from immunotherapy
T cells tackle new ‘Pirola’ SARS-CoV-2 variant
LJI scientists harness bioinformatics to predict how T cells may adapt to fighting the highly mutated Pirola variant
No IKAROS, no antibodies
Researchers map the genome to figure out how a protein called IKAROS controls healthy B cell development
From the COVID generation, a new kind of inventor
Local student Maya Krishnan hopes to improve biosafety for healthcare workers. LJI's Laurence Cagnon shares her expertise and mentorship.